A pH-induced conformational switch in a tyrosine kinase inhibitor identified by electronic spectroscopy and quantum

Muhammad Khattab1, Feng Wang2,3,4, Andrew H A Clayton5

  • 1Centre for Micro-Photonics, Faculty of Science, Engineering and Technology, Swinburne University of Technology, Melbourne, Victoria, 3122, Australia.

Scientific Reports
|November 28, 2017
PubMed

Insights

Tyrosine kinase inhibitors (TKIs) undergo structural changes with pH. This study reveals pH-induced conformational transitions in the TKI AG1478, impacting its electronic absorption spectrum and structure.

Area of Science:

  • Biochemistry
  • Chemical Physics
  • Medicinal Chemistry

Background:

  • Tyrosine kinase inhibitors (TKIs) are crucial in clinical treatments.
  • TKIs encounter varying pH environments during drug delivery, potentially altering their structure.
  • Understanding pH-dependent TKI behavior is vital for drug efficacy.

Purpose of the Study:

  • To investigate the pH-dependent structural and spectral properties of the TKI AG1478.
  • To elucidate the conformational changes of AG1478 across different pH conditions.
  • To determine the pKa value of AG1478 and its implications.

Main Methods:

  • UV-Vis spectroscopy was employed to monitor spectral changes of AG1478 at varying pH.
  • Time-dependent density functional theory (TD-DFT) calculations were performed.
  • The conductor-like polarizable continuum model (CPCM) was used to simulate solvent effects.

Main Results:

  • AG1478 exhibited a 10 nm spectral shift from acidic to neutral pH.
  • In alkaline conditions, the spectrum split, indicating distinct species.
  • The calculated pKa value for AG1478 was 5.58 ± 0.01.
  • Computational analysis assigned spectra to protonated and neutral conformers.

Conclusions:

  • AG1478 undergoes significant pH-induced conformational transitions.
  • Protonation states and conformers vary with pH, affecting spectral properties.
  • These findings highlight the importance of pH in TKI drug design and delivery.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...